Developer docs
API playgroundTry for free, no card

Search company profiles

RadNet

Full company profile

uuid0000oku

Namestring
RadNet
Legal namestring
RadNet, Inc.
Websiteurl
radnet.com
Company typeenum
Public
Founded yearint
1980
Descriptiontext

RadNet, Inc. (NASDAQ: RDNT) is the largest provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, operating 440 centers across 11 states (AZ, CA, DE, FL, ID, IN, MD, NJ, NY, TX, VA) as of May 2026 and completing more than 11.5 million imaging procedures annually. The company generates fee-for-service revenue from MRI, CT, PET/CT, mammography, X-ray, and ultrasound procedures reimbursed by Medicare, Medicaid, commercial payors, and patients, with additional managed-service revenue from hospital and health-system joint ventures including Trinity Health Saint Alphonsus (Idaho).

RadNet's technology stack is anchored by its wholly owned DeepHealth subsidiary, an AI-powered radiology platform covering all major imaging modalities with 26 FDA-cleared devices and CE marks following acquisitions of Gleamer SAS (€230M), iCAD ($103M), Cimar UK, See-Mode Technologies, Aidence, and Quantib. Proprietary products include the DeepHealth Breast Suite (21% increase in breast cancer detection in a study of 579,000+ women), Reporting Pro (generative AI radiology reporting with speech recognition), TechLive (remote scanner operations with 42% reduction in MR room closure hours), and the eRAD cloud-based radiology information system. DeepHealth commercializes AI software externally through 2,700+ customer contracts across 50+ countries and operates as a SaaS business targeting $140M+ ARR by year-end 2026.

The company combines an enterprise field sales motion for hospital JV and AI software sales with direct-to-consumer marketing for patient acquisition across its owned center network. Founded in 1980 and headquartered in Los Angeles, RadNet has grown from approximately 6,000 employees and 150 centers to roughly 11,000 employees and 440+ centers, supplemented by a digital health division in Somerville, Massachusetts. The company is led by co-founder and CEO Dr. Howard Berger (since 1980) and CFO Mark Stolper (since 2004), with Kees Wesdorp overseeing the DeepHealth digital health division.

Short descriptiontext

RadNet is the largest US operator of freestanding outpatient diagnostic imaging centers, running 440 facilities across 11 states that complete 11.5M+ procedures annually, while monetizing AI radiology software through its DeepHealth subsidiary across 50+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
outpatient diagnostic imaging, radiology AI solutions, medical imaging services, mammography screening centers, imaging workflow software
Industry7 codes
PRIMARYHLAFAKAA
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAC
Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAI
Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAFAKAB
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
SECONDARYHLAFAJAJ
Women’s Imaging & Breast Health Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Ambulatory Health Care Services621
SIC code1 code
  • Services-Health Services8000
Product category
Outpatient Diagnostic Imaging Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Imaging Center Services
TypeSubscription Recurring
Description

Fee-for-service outpatient diagnostic imaging services including MRI, CT, PET/CT, mammography, X-ray, and ultrasound across over 440 centers; revenue from payors (Medicare, Medicaid, commercial insurers) and patients

radnet.com
2Digital Health / AI Solutions
TypeSubscription Recurring
Description

SaaS-based AI-powered radiology solutions through DeepHealth subsidiary; annual recurring revenue model targeting $140 million+ ARR by end of 2026; includes FDA-cleared clinical AI tools deployed across imaging modalities

stocktitan.net
3Hospital Joint Ventures
TypeManaged Services
Description

Strategic partnerships with hospitals and health systems where RadNet manages imaging operations; revenue share or management fees; helps hospitals shift imaging to outpatient settings

finance.yahoo.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain, Others
Pricing details1 tier
1DeepHealth ARR target of $140M+ by 2026 with 45-55% growth rate
ModelSubscriptionBilling cadenceAnnual
Notes

SaaS subscription model for AI radiology tools with annual recurring revenue structure

in.investing.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 6 records shown
1DeepHealth
Description

Wholly-owned subsidiary providing AI-powered radiology solutions including breast, lung, prostate, and brain imaging AI tools; FDA-cleared clinical AI products; radiology workflow automation; operates under DeepHealth OS platform

investing.com
+5 more records
Core offering1 text field

RadNet operates the largest US network of freestanding, fixed-site outpatient diagnostic imaging centers, providing MRI, CT, PET/CT, mammography, X-ray, and ultrasound services across 440 centers in 11 states. Through its DeepHealth subsidiary, RadNet develops and sells AI-powered radiology software solutions, cloud-based imaging management (eRAD), and clinical AI tools for breast, lung, prostate, and brain imaging, serving external customers in over 50 countries alongside internal deployment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 21% increase in breast cancer detection rates using AI-powered mammography (study of 579,000+ women)
+3 more records
Product overview1 text field

RadNet operates as both a healthcare services provider and a technology company, combining a network of 440 outpatient diagnostic imaging centers across 11 U.S. states with AI-powered digital health solutions through its DeepHealth subsidiary. The core offering consists of outpatient imaging services (MRI, CT, PET/CT, mammography, X-ray, ultrasound) supported by the eRAD radiology information and image management system. The DeepHealth AI platform, which RadNet describes as the world's largest provider of radiology clinical AI solutions, integrates specialized modules including the Breast Suite for mammography AI (with BAC Assessment and Mammo Dx FDA clearances), Reporting Pro for AI-powered radiology reporting, and TechLive for remote imaging operations. The company completed over 11.5 million outpatient imaging procedures annually as of December 2025.

Product and service10 records
1Outpatient Imaging Centers
CategoryDiagnostic Imaging Services
Description

Largest network of freestanding, fixed-site outpatient diagnostic imaging centers in the US offering MRI, CT, PET/CT, mammography, X-ray, and ultrasound services to patients across 11 states (AZ, CA, DE, FL, ID, IN, MD, NJ, NY, TX, VA).

2DeepHealth AI Platform
CategoryAI Radiology Software
Description

Wholly-owned subsidiary providing AI-powered radiology solutions, including clinical AI tools for breast, lung, prostate, and brain imaging, operating on the DeepHealth OS platform with cloud-based clinical imaging management. Deployed across RadNet's network and sold to external customers in 50+ countries.

3eRAD
CategoryImaging Workflow Software
Description

Integrated web-based, cloud Radiology Information System (RIS) and image management solutions for medical imaging workflow, sold to external customers and used internally across RadNet's center network.

4DeepHealth Breast Suite
CategoryAI Mammography Module
Description

AI-powered mammography workflow suite integrating with GE HealthCare's Senographe Pristina system to improve breast cancer detection. Clinical studies show 21% increase in breast cancer detection rates across 579,000+ women.

5BAC Assessment
CategoryAI Clinical Module
Description

FDA 510(k) cleared AI tool that detects cardiovascular disease risk indicators through breast arterial calcification assessment during routine mammograms, demonstrating over 90% sensitivity and 88% specificity across dense and non-dense breast tissue.

6Mammo Dx
CategoryAI Clinical Module
Description

FDA 510(k) cleared AI tool that compares prior and current mammography exams to improve cancer detection accuracy; deployed across RadNet's imaging center network and commercially available in the United States.

7Reporting Pro
CategoryAI Reporting Software
Description

AI-powered radiology reporting solution that integrates speech recognition, clinical AI findings, measurements, and generative AI-generated impressions into a unified workflow, addressing radiologist shortages projected at 15% in the US by 2029 and 40% in parts of Europe by 2030.

8TechLive
CategoryRemote Operations Platform
Description

FDA-cleared and CE-marked remote imaging solution enabling certified technologists to remotely operate and manage MR, CT, PET/CT, and ultrasound scanners through a consolidated interface. Demonstrated 42% reduction in MR room closure hours and 27% increase in advanced breast MRI procedures.

9CIMAR UK Cloud Imaging Platform
CategoryCloud Imaging Platform
Description

Cloud-native healthcare image management platform integrated into DeepHealth, serving 50% of NHS trusts and 80% of UK private hospital groups with imaging data connectivity and lung cancer screening program support.

10Hospital and Health System Joint Ventures
CategoryManaged Imaging Services
Description

Strategic joint ventures with hospitals and health systems where RadNet manages imaging operations and deploys DeepHealth AI technology, helping hospitals shift imaging to outpatient settings while earning management fees or revenue share.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

Joint venture through acquisition of majority equity position in Intermountain Medical Imaging LLC, jointly operating five imaging facilities in Boise, Idaho area. RadNet assumes management of all five locations and implements DeepHealth AI technology. Projected to generate approximately $30 million in annual revenue. Deal marks RadNet's 11th state and second new state in 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-16
Description

Expanded collaboration to commercialize AI-powered mammography tools globally. DeepHealth's Breast Suite AI integrated with GE HealthCare's Senographe Pristina mammography system. New applications include ProFound Pro and Safeguard Review. Clinical studies show 21% increase in breast cancer detection rates using AI-driven workflow. Partnership extends internationally with Pristina Via system.

3Gleamer SAS
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-02
Description

Acquired Paris-based radiology AI company for up to €230 million ($267-270M). Makes DeepHealth the world's largest provider of radiology clinical AI solutions worldwide with 2,700+ customer contracts across 50+ countries. Gleamer brings FDA-cleared and CE-marked AI solutions covering musculoskeletal, breast, lung, and neurologic indications. Expected ARR of approximately $30 million in 2026 with 90%+ CAGR from 2022-2025.

radiologybusiness.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-03
Description

Acquisition of outpatient imaging assets marking RadNet's entry into Midwest with six multimodality imaging centers in greater Indianapolis, Indiana area. Expected to add approximately $18 million in annual revenue. Northwest Radiology's 18 radiologists continue providing contracted professional services.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-11-11
Description

Acquisition of Cimar UK to enhance AI-powered imaging and data connectivity capabilities. Cimar's cloud-native infrastructure and existing NHS partnerships integrated into DeepHealth subsidiary. Supports earlier disease detection and expansion of digital health services across UK and Europe, particularly in lung cancer screening programs.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-07-01
Description

Acquired iCAD Inc. for approximately $103 million to strengthen AI-powered breast cancer detection capabilities. Integration of iCAD's imaging and risk evaluation technologies into DeepHealth portfolio, accelerating AI-powered breast health technologies.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-11-01
Description

Acquired 75% interest in London-based provider of lung cancer screening services to UK NHS. Part of strategy to implement early detection screening for cancers and chronic diseases. Program could lead to over one million lung scans in England by 2026.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest outpatient diagnostic imaging networks in the US operating hundreds of centers across multiple states with MRI, CT, ultrasound, mammography, and X-ray offerings. Most directly comparable to RadNet's core outpatient imaging center business by modality mix and patient segment.

TypeDirect peer
Description

Multi-modality outpatient diagnostic imaging provider operating a national network of fixed-site imaging centers in the US with a similar MRI/CT/mammography portfolio. Directly competes with RadNet in regional markets and pursues a similar outpatient-shifting strategy versus hospital-based imaging.

TypeDirect peer
Description

PE-backed (Welsh Carson) operator of outpatient imaging centers across multiple US states, formed through roll-up acquisitions of regional radiology practices. Closely comparable to RadNet's hub-and-spoke acquisition model and hospital joint venture approach.

TypeDirect peer
Description

Outpatient imaging network owned by InTandem Capital Partners operating diagnostic imaging centers across the US with MRI, CT, and women's imaging services. Similar fixed-site outpatient model and patient payor mix to RadNet's center operations.

TypeBroad incumbent
Description

Global medical imaging hardware and informatics incumbent with mammography (Senographe Pristina), MRI, CT, and AI-enabled imaging software. Both a strategic partner (DeepHealth Breast Suite integration) and a competitor in the AI radiology space.

TypeBroad incumbent
Description

Global medical imaging OEM with MRI, CT, PET, and AI-Rad Companion radiology AI portfolio. Provides comparable MRI/CT equipment and competes with DeepHealth through native AI bundling and broad enterprise contracts with hospitals.

7Philips Healthcare
TypeBroad incumbent
Description

Medical imaging, diagnostic informatics, and AI vendor serving radiology departments worldwide. Competes in imaging informatics (PACS/RIS) where eRAD also operates, and bundles AI capabilities alongside Intellispace Portal offerings.

TypeBroad incumbent
Description

Women's health and mammography hardware/software leader including 3Dimensions mammography systems and Genius AI Detection software. Directly overlaps with RadNet's DeepHealth Breast Suite and MammogramNow offerings in breast cancer screening AI.

TypeEmerging player
Description

AI radiology vendor with FDA-cleared algorithms for CT triage and detection across multiple modalities, deployed across hundreds of hospital systems. Comparable as a standalone AI clinical solutions provider competing with DeepHealth for radiology AI contracts.

TypeEmerging player
Description

Mumbai-based radiology AI company with FDA-cleared and CE-marked solutions for chest CT, head CT, and chest X-ray, sold across 50+ countries. Overlaps with Gleamer's geographic reach and competes for similar AI imaging deployment customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks3 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries10 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A16 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RadNet

Outpatient Diagnostic Imaging Servicesradnet.com

RadNet is the largest US operator of freestanding outpatient diagnostic imaging centers, running 440 facilities across 11 states that complete 11.5M+ procedures annually, while monetizing AI radiology software through its DeepHealth subsidiary across 50+ countries.

What RadNet does

RadNet, Inc. (NASDAQ: RDNT) is the largest provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, operating 440 centers across 11 states (AZ, CA, DE, FL, ID, IN, MD, NJ, NY, TX, VA) as of May 2026 and completing more than 11.5 million imaging procedures annually. The company generates fee-for-service revenue from MRI, CT, PET/CT, mammography, X-ray, and ultrasound procedures reimbursed by Medicare, Medicaid, commercial payors, and patients, with additional managed-service revenue from hospital and health-system joint ventures including Trinity Health Saint Alphonsus (Idaho).

RadNet's technology stack is anchored by its wholly owned DeepHealth subsidiary, an AI-powered radiology platform covering all major imaging modalities with 26 FDA-cleared devices and CE marks following acquisitions of Gleamer SAS (€230M), iCAD ($103M), Cimar UK, See-Mode Technologies, Aidence, and Quantib. Proprietary products include the DeepHealth Breast Suite (21% increase in breast cancer detection in a study of 579,000+ women), Reporting Pro (generative AI radiology reporting with speech recognition), TechLive (remote scanner operations with 42% reduction in MR room closure hours), and the eRAD cloud-based radiology information system. DeepHealth commercializes AI software externally through 2,700+ customer contracts across 50+ countries and operates as a SaaS business targeting $140M+ ARR by year-end 2026.

The company combines an enterprise field sales motion for hospital JV and AI software sales with direct-to-consumer marketing for patient acquisition across its owned center network. Founded in 1980 and headquartered in Los Angeles, RadNet has grown from approximately 6,000 employees and 150 centers to roughly 11,000 employees and 440+ centers, supplemented by a digital health division in Somerville, Massachusetts. The company is led by co-founder and CEO Dr. Howard Berger (since 1980) and CFO Mark Stolper (since 2004), with Kees Wesdorp overseeing the DeepHealth digital health division.

RadNet firmographics

Firmographics
Name
RadNet
Legal name
RadNet, Inc.
Website
https://radnet.com
Company type
Public
Founded year
1980
Operating status
Operating
Headcount range
10,001+ employees
Short description
RadNet is the largest US operator of freestanding outpatient diagnostic imaging centers, running 440 facilities across 11 states that complete 11.5M+ procedures annually, while monetizing AI radiology software through its DeepHealth subsidiary across 50+ countries.
Ownership category
akta.pro rank

RadNet industry classification

Industry
Product category
Outpatient Diagnostic Imaging Services
NAICS
Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAFAKAA
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAC
Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAI
Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAFAKAB
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
SECONDARYHLAFAJAJ
Women’s Imaging & Breast Health Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

Keywords

  • Outpatient diagnostic imaging
  • Radiology AI solutions
  • Medical imaging services
  • Mammography screening centers
  • Imaging workflow software

Where RadNet is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices5 records

Markets served

RadNet business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

  1. Imaging Center Services: Fee-for-service outpatient diagnostic imaging services including MRI, CT, PET/CT, mammography, X-ray, and ultrasound across over 440 centers; revenue from payors (Medicare, Medicaid, commercial insurers) and patients
  2. Digital Health / AI Solutions: SaaS-based AI-powered radiology solutions through DeepHealth subsidiary; annual recurring revenue model targeting $140 million+ ARR by end of 2026; includes FDA-cleared clinical AI tools deployed across imaging modalities
  3. Hospital Joint Ventures: Strategic partnerships with hospitals and health systems where RadNet manages imaging operations; revenue share or management fees; helps hospitals shift imaging to outpatient settings

Pricing tiers

ModelBillingPrice
SubscriptionAnnualDeepHealth ARR target of $140M+ by 2026 with 45-55% growth rate

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

RadNet product offering

Product offering

Core offering

RadNet operates the largest US network of freestanding, fixed-site outpatient diagnostic imaging centers, providing MRI, CT, PET/CT, mammography, X-ray, and ultrasound services across 440 centers in 11 states. Through its DeepHealth subsidiary, RadNet develops and sells AI-powered radiology software solutions, cloud-based imaging management (eRAD), and clinical AI tools for breast, lung, prostate, and brain imaging, serving external customers in over 50 countries alongside internal deployment.

Product overview

RadNet operates as both a healthcare services provider and a technology company, combining a network of 440 outpatient diagnostic imaging centers across 11 U.S. states with AI-powered digital health solutions through its DeepHealth subsidiary. The core offering consists of outpatient imaging services (MRI, CT, PET/CT, mammography, X-ray, ultrasound) supported by the eRAD radiology information and image management system. The DeepHealth AI platform, which RadNet describes as the world's largest provider of radiology clinical AI solutions, integrates specialized modules including the Breast Suite for mammography AI (with BAC Assessment and Mammo Dx FDA clearances), Reporting Pro for AI-powered radiology reporting, and TechLive for remote imaging operations. The company completed over 11.5 million outpatient imaging procedures annually as of December 2025.

Differentiator

Problem solved

Functional benefit

Brands

  • DeepHealth: Wholly-owned subsidiary providing AI-powered radiology solutions including breast, lung, prostate, and brain imaging AI tools; FDA-cleared clinical AI products; radiology workflow automation; operates under DeepHealth OS platform
  • eRAD
  • DeepHealth Breast Suite
  • Reporting Pro
  • TechLive
  • MammogramNow

Products and services

  • Outpatient Imaging Centers Largest network of freestanding, fixed-site outpatient diagnostic imaging centers in the US offering MRI, CT, PET/CT, mammography, X-ray, and ultrasound services to patients across 11 states (AZ, CA, DE, FL, ID, IN, MD, NJ, NY, TX, VA).
  • DeepHealth AI Platform Wholly-owned subsidiary providing AI-powered radiology solutions, including clinical AI tools for breast, lung, prostate, and brain imaging, operating on the DeepHealth OS platform with cloud-based clinical imaging management. Deployed across RadNet's network and sold to external customers in 50+ countries.
  • eRAD Integrated web-based, cloud Radiology Information System (RIS) and image management solutions for medical imaging workflow, sold to external customers and used internally across RadNet's center network.
  • DeepHealth Breast Suite AI-powered mammography workflow suite integrating with GE HealthCare's Senographe Pristina system to improve breast cancer detection. Clinical studies show 21% increase in breast cancer detection rates across 579,000+ women.
  • BAC Assessment FDA 510(k) cleared AI tool that detects cardiovascular disease risk indicators through breast arterial calcification assessment during routine mammograms, demonstrating over 90% sensitivity and 88% specificity across dense and non-dense breast tissue.
  • Mammo Dx FDA 510(k) cleared AI tool that compares prior and current mammography exams to improve cancer detection accuracy; deployed across RadNet's imaging center network and commercially available in the United States.
  • Reporting Pro AI-powered radiology reporting solution that integrates speech recognition, clinical AI findings, measurements, and generative AI-generated impressions into a unified workflow, addressing radiologist shortages projected at 15% in the US by 2029 and 40% in parts of Europe by 2030.
  • TechLive FDA-cleared and CE-marked remote imaging solution enabling certified technologists to remotely operate and manage MR, CT, PET/CT, and ultrasound scanners through a consolidated interface. Demonstrated 42% reduction in MR room closure hours and 27% increase in advanced breast MRI procedures.
  • CIMAR UK Cloud Imaging Platform Cloud-native healthcare image management platform integrated into DeepHealth, serving 50% of NHS trusts and 80% of UK private hospital groups with imaging data connectivity and lung cancer screening program support.
  • Hospital and Health System Joint Ventures Strategic joint ventures with hospitals and health systems where RadNet manages imaging operations and deploys DeepHealth AI technology, helping hospitals shift imaging to outpatient settings while earning management fees or revenue share.

Quantifiable outcome

  • 21% increase in breast cancer detection rates using AI-powered mammography (study of 579,000+ women)
  • +3 more outcomes

Companies that use RadNet

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

RadNet technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

RadNet partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and major.

  • Trinity Health Saint Alphonsus Health SystemcoreStrategic or Co-development Partner · 30 April 2026Joint venture through acquisition of majority equity position in Intermountain Medical Imaging LLC, jointly operating five imaging facilities in Boise, Idaho area. RadNet assumes management of all five locations and implements DeepHealth AI technology. Projected to generate approximately $30 million in annual revenue. Deal marks RadNet's 11th state and second new state in 2026.
  • GE HealthCarecoreStrategic or Co-development Partner · 16 April 2026Expanded collaboration to commercialize AI-powered mammography tools globally. DeepHealth's Breast Suite AI integrated with GE HealthCare's Senographe Pristina mammography system. New applications include ProFound Pro and Safeguard Review. Clinical studies show 21% increase in breast cancer detection rates using AI-driven workflow. Partnership extends internationally with Pristina Via system.
  • Gleamer SAScoreTechnology or Integration · 2 March 2026Acquired Paris-based radiology AI company for up to €230 million ($267-270M). Makes DeepHealth the world's largest provider of radiology clinical AI solutions worldwide with 2,700+ customer contracts across 50+ countries. Gleamer brings FDA-cleared and CE-marked AI solutions covering musculoskeletal, breast, lung, and neurologic indications. Expected ARR of approximately $30 million in 2026 with 90%+ CAGR from 2022-2025.
  • Northwest Radiology NetworkmajorStrategic or Co-development Partner · 3 February 2026Acquisition of outpatient imaging assets marking RadNet's entry into Midwest with six multimodality imaging centers in greater Indianapolis, Indiana area. Expected to add approximately $18 million in annual revenue. Northwest Radiology's 18 radiologists continue providing contracted professional services.
  • Cimar UKmajorTechnology or Integration · 11 November 2025Acquisition of Cimar UK to enhance AI-powered imaging and data connectivity capabilities. Cimar's cloud-native infrastructure and existing NHS partnerships integrated into DeepHealth subsidiary. Supports earlier disease detection and expansion of digital health services across UK and Europe, particularly in lung cancer screening programs.
  • iCAD Inc.majorTechnology or Integration · 1 July 2025Acquired iCAD Inc. for approximately $103 million to strengthen AI-powered breast cancer detection capabilities. Integration of iCAD's imaging and risk evaluation technologies into DeepHealth portfolio, accelerating AI-powered breast health technologies.
  • Heart & Lung Imaging LimitedmajorStrategic or Co-development Partner · 1 November 2022Acquired 75% interest in London-based provider of lung cancer screening services to UK NHS. Part of strategy to implement early detection screening for cancers and chronic diseases. Program could lead to over one million lung scans in England by 2026.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

RadNet competitors and assessment

Company assessment

Direct peers

  • SimonMed Imaging: One of the largest outpatient diagnostic imaging networks in the US operating hundreds of centers across multiple states with MRI, CT, ultrasound, mammography, and X-ray offerings. Most directly comparable to RadNet's core outpatient imaging center business by modality mix and patient segment.
  • Akumin: Multi-modality outpatient diagnostic imaging provider operating a national network of fixed-site imaging centers in the US with a similar MRI/CT/mammography portfolio. Directly competes with RadNet in regional markets and pursues a similar outpatient-shifting strategy versus hospital-based imaging.
  • US Radiology Specialists: PE-backed (Welsh Carson) operator of outpatient imaging centers across multiple US states, formed through roll-up acquisitions of regional radiology practices. Closely comparable to RadNet's hub-and-spoke acquisition model and hospital joint venture approach.
  • Center for Diagnostic Imaging (CDI): Outpatient imaging network owned by InTandem Capital Partners operating diagnostic imaging centers across the US with MRI, CT, and women's imaging services. Similar fixed-site outpatient model and patient payor mix to RadNet's center operations.

Broad incumbents

  • GE HealthCare: Global medical imaging hardware and informatics incumbent with mammography (Senographe Pristina), MRI, CT, and AI-enabled imaging software. Both a strategic partner (DeepHealth Breast Suite integration) and a competitor in the AI radiology space.
  • Siemens Healthineers: Global medical imaging OEM with MRI, CT, PET, and AI-Rad Companion radiology AI portfolio. Provides comparable MRI/CT equipment and competes with DeepHealth through native AI bundling and broad enterprise contracts with hospitals.
  • Philips Healthcare: Medical imaging, diagnostic informatics, and AI vendor serving radiology departments worldwide. Competes in imaging informatics (PACS/RIS) where eRAD also operates, and bundles AI capabilities alongside Intellispace Portal offerings.
  • Hologic: Women's health and mammography hardware/software leader including 3Dimensions mammography systems and Genius AI Detection software. Directly overlaps with RadNet's DeepHealth Breast Suite and MammogramNow offerings in breast cancer screening AI.

Emerging players

  • Aidoc: AI radiology vendor with FDA-cleared algorithms for CT triage and detection across multiple modalities, deployed across hundreds of hospital systems. Comparable as a standalone AI clinical solutions provider competing with DeepHealth for radiology AI contracts.
  • Qure.ai: Mumbai-based radiology AI company with FDA-cleared and CE-marked solutions for chest CT, head CT, and chest X-ray, sold across 50+ countries. Overlaps with Gleamer's geographic reach and competes for similar AI imaging deployment customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks3 records

Key highlights7 records

Customer concentration

RadNet social profiles

Digital presence

RadNet compliance and trust

Trust signal

Compliance1 record

RadNet financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RadNet leadership team

Management profile

Number of profiles

Profiles13 records

RadNet subsidiaries and ownership

Company hierarchy

Subsidiaries10 records

RadNet funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RadNet M&A and investment

M&A and investment

M&A16 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RadNet

What does RadNet do?

RadNet operates the largest US network of freestanding, fixed-site outpatient diagnostic imaging centers, providing MRI, CT, PET/CT, mammography, X-ray, and ultrasound services across 440 centers in 11 states. Through its DeepHealth subsidiary, RadNet develops and sells AI-powered radiology software solutions, cloud-based imaging management (eRAD), and clinical AI tools for breast, lung, prostate, and brain imaging, serving external customers in over 50 countries alongside internal deployment.

Is RadNet a public or private company?

RadNet is a public company. It is classified as public and is currently operating.

When was RadNet founded?

RadNet was founded in 1980. It employs 10,001+ people.

Where is RadNet based?

RadNet is headquartered in Los Angeles, United States, in the North America region.

How does RadNet make money?

Three revenue lines are on record. Imaging Center Services are the primary driver. The others are digital Health / AI Solutions and hospital Joint Ventures.

Who are RadNet's main competitors?

Direct peers on record are SimonMed Imaging, Akumin, US Radiology Specialists and Center for Diagnostic Imaging (CDI). Broad incumbents are GE HealthCare, Siemens Healthineers, Philips Healthcare and Hologic. Emerging players are Aidoc and Qure.ai.

Does RadNet have an API?

No public API is recorded for RadNet.

What industry is RadNet in?

RadNet's product category is Outpatient Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound), with a secondary code of HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic). Its NAICS code is 621512 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldAlphaCore Capital LLC Makes New Investment in RadNet, Inc. $RDNTAlphaCore Capital LLC acquired a new position in RadNet, Inc. in Q3, buying 12,338 shares valued at about $851,000. The company's stock opened at $76.42, with a consensus price target of $89.67. RadNet reported Q3 EPS of $0.30, beating estimates.American Banking and Market NewsRadNet (NASDAQ:RDNT) Stock Gets Price Target Increase from KeyCorpKeyCorp raised its price target on RadNet from $92 to $95, keeping an overweight rating. The consensus rating is Moderate Buy with a target of $90.43. RadNet reported Q3 EPS of $0.30, beating estimates, with revenue up 22.1% year-over-year.YahooRadNet (RDNT) Could Be 18% Undervalued After Its Acquisition Focus Came Into ViewRadNet signaled a more acquisition-focused phase after its Q3 2026 update, with management highlighting a sizable cash position and plans for tuck-in deals. The stock is up 9.9% over the past month, while analysts see it undervalued at $94.63 fair value versus a $77.94 close. The narrative hinges on converting AI and digital health investments into higher margins and free cash flow.Simply Wall StIs RadNet (RDNT) Pricing In Too Much Sales Optimism?RadNet's stock trades at a 2.6x sales multiple, above the healthcare sector average of 1.3x, and the company has returned 152.6% over five years. The valuation prices in record Q3 2026 revenue and the ONRAD acquisition, leaving little room for disappointment if execution misses expectations.YahooRecord Q3 Results Could Be A Big Moment For RadNet Stock (RDNT)RadNet reported record Q3 2026 revenue of $638.26 million, up from $522.87 million a year earlier, and raised full-year guidance. Adjusted diluted EPS of $0.30 beat consensus of $0.21, with digital health revenue rising 32.7%. The company plans tuck-in acquisitions and efficiency deals, citing a cash balance of $750.6 million.The Motley FoolRadNet: 3 Key Takeaways for Long-Term InvestorsRadNet reported record Q3 2026 revenue of $638 million, driven by rising demand for advanced imaging. The company is expanding into hospital systems through its pending ONRAD acquisition, adding 225 locations across 26 states. Its Digital Health segment's external ARR more than doubled to $73 million, now 65% of total ARR.Seeking AlphaRadNet targets $140m+ Digital Health ARR by year-end while raising 2026 Imaging Center free cash flow to $120m-$130m (NASDAQ:RDNT)RadNet reported record Q3 2026 revenue of $638.3 million and adjusted EBITDA of $105 million, both quarterly records. Management raised 2026 Imaging Center free cash flow guidance to $120–130 million and forecast Digital Health ARR above $140 million by year-end. The pending ONRAD acquisition will add $190–200 million in revenue in its first year.YahooRadNet: Q3 Earnings SnapshotRadNet reported Q3 net income of $4.2 million, or 5 cents per share, beating analyst estimates of 21 cents. Revenue of $638.3 million also exceeded forecasts, and the company expects full-year revenue between $2.38 billion and $2.44 billion.The future of tradingRadNet Q3 adjusted EBITDA rises 24% to $105.04 millionRadNet reported Q3 2026 adjusted EBITDA of $105.04 million, up 24% year over year, with quarterly revenue of $638.3 million, up 22%. Advanced imaging procedural volumes rose 20% year over year, and the company raised its full-year 2026 Imaging Center adjusted EBITDA guidance to $350–$363 million.FinancialContent Business PageEarnings to watch: RadNet (RDNT) reports Q3 results tomorrowRadNet will report Q3 earnings before market open. The company beat revenue expectations last quarter with $622.7 million, up 25% year on year. Analysts expect 21.6% growth this quarter, and the stock is up 7% with an average price target of $94.63.